Results 201 to 210 of about 51,006 (322)
Conceivability arguments against physicalism or how to slay zombies and banish spectres
Liam Shannon Dwyer
openalex +2 more sources
A fatal 3‐chloro‐phencyclidine (3‐Cl‐PCP) intoxication was investigated by analyzing postmortem samples and a pooled human liver microsomes assay. Tentative metabolite identification was performed by liquid chromatography‐quadrupole time‐of‐flight mass spectrometry (LC‐QTOF‐MS). Seven phase I metabolites were identified.
Johannes Kutzler +3 more
wiley +1 more source
Neuroethics and AI ethics: a proposal for collaboration. [PDF]
Salles A, Farisco M.
europepmc +1 more source
We develop a highly cost‐effective heterogeneous catalyst for efficient CO2 conversion to propiolic acid under mild conditions via a nano‐confined approach with porous MIL support. ABSTRACT Efficient conversion of carbon dioxide to organics has been a promising outlet for value‐added carbon dioxide consumption.
Bin Lei +6 more
wiley +1 more source
Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad +9 more
wiley +1 more source
Transcendental Arguments, Conceivability, and Global Vs. Local Skepticism
Moti Mizrahi
semanticscholar +1 more source
The regio‐ and stereoselective synthesis of ring‐fused α‐hydroxy‐2‐cyclopentenones is achieved by a one‐pot gold(I)‐catalyzed Rautenstrauch rearrangement/nitrosocarbonyl hetero‐Diels–Alder reaction/ring opening sequence carried out on suitable propargyl esters followed by selective NO bond cleavage.
Dina Scarpi +3 more
wiley +1 more source
Text Messaging Between Patients With Inflammatory Rheumatic Diseases and Pharmacists to Solve Drug-Related Problems: Prospective Feasibility Study. [PDF]
Haegens LL +4 more
europepmc +1 more source

